APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Coagulation Factor IX

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Human Coagulation Factor IX Market Analysis and Forecast 2026-2032

Report ID 174031480223 December 2025196 pages

Choose your research edition.

Industry ResearchRecombinant Human Coagulation Factor IX Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Coagulation Factor IX Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Recombinant Human Coagulation Factor IX Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Coagulation Factor IX Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Coagulation Factor IX Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Recombinant Human Coagulation Factor IX market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Human Coagulation Factor IX is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Human Coagulation Factor IX is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Human Coagulation Factor IX is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Human Coagulation Factor IX is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant Human Coagulation Factor IX include Bio-Techne, Cayman, Cusabio, Grifols, IDELVION, NovoPro Bioscience, Octapharma, Sino Biological and Baxter, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Human Coagulation Factor IX, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Human Coagulation Factor IX, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Human Coagulation Factor IX, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human Coagulation Factor IX sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Human Coagulation Factor IX market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Human Coagulation Factor IX sales, projected growth trends, production technology, application and end-user industry.

Recombinant Human Coagulation Factor IX Segment by Company

Bio-Techne

Cayman

Cusabio

Grifols

IDELVION

NovoPro Bioscience

Octapharma

Sino Biological

Baxter

Biogen

Diagbio

Hualan Bio

Sanofi

ChinaBiologic

Shuyang

Recombinant Human Coagulation Factor IX Segment by Type

500 IU/Bottle

250 IU/Bottle

2000 IU/Bottle

1000 IU/Bottle

Recombinant Human Coagulation Factor IX Segment by Application

Adult Patients

Child Patients

Recombinant Human Coagulation Factor IX Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Coagulation Factor IX market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Coagulation Factor IX and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Coagulation Factor IX.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant Human Coagulation Factor IX in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant Human Coagulation Factor IX manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Coagulation Factor IX sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Human Coagulation Factor IX Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 500 IU/Bottle Major Manufacturers Table 3. 250 IU/Bottle Major Manufacturers Table 4. 2000 IU/Bottle Major Manufacturers Table 5. 1000 IU/Bottle Major Manufacturers Table 6. Global Recombinant Human Coagulation Factor IX Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Adult Patients Major Manufacturers Table 8. Child Patients Major Manufacturers Table 9. Recombinant Human Coagulation Factor IX Industry Trends Table 10. Recombinant Human Coagulation Factor IX Industry Drivers Table 11. Recombinant Human Coagulation Factor IX Industry Opportunities and Challenges Table 12. Recombinant Human Coagulation Factor IX Industry Restraints Table 13. Global Recombinant Human Coagulation Factor IX Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Recombinant Human Coagulation Factor IX Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Recombinant Human Coagulation Factor IX Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Region (2021-2026) Table 17. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Region (2027-2032) Table 18. Global Recombinant Human Coagulation Factor IX Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Recombinant Human Coagulation Factor IX Sales by Region (2021-2026) & (k units) Table 20. Global Recombinant Human Coagulation Factor IX Sales by Region (2027-2032) & (k units) Table 21. Global Recombinant Human Coagulation Factor IX Sales Market Share by Region (2021-2026) Table 22. Global Recombinant Human Coagulation Factor IX Sales Market Share by Region (2027-2032) Table 23. Global Recombinant Human Coagulation Factor IX Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Recombinant Human Coagulation Factor IX Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Recombinant Human Coagulation Factor IX Sales Market Share by Manufacturers (2021-2026) Table 27. Global Recombinant Human Coagulation Factor IX Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Recombinant Human Coagulation Factor IX Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Recombinant Human Coagulation Factor IX Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Recombinant Human Coagulation Factor IX Manufacturers, Product Type & Application Table 31. Global Recombinant Human Coagulation Factor IX Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Recombinant Human Coagulation Factor IX by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Recombinant Human Coagulation Factor IX Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Recombinant Human Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Recombinant Human Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Type (2021-2026) Table 38. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Type (2027-2032) Table 39. Global Recombinant Human Coagulation Factor IX Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Recombinant Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 41. Global Recombinant Human Coagulation Factor IX Sales by Type (2027-2032) & (k units) Table 42. Global Recombinant Human Coagulation Factor IX Sales Market Share by Type (2021-2026) Table 43. Global Recombinant Human Coagulation Factor IX Sales Market Share by Type (2027-2032) Table 44. Global Recombinant Human Coagulation Factor IX Price by Type (2021-2026) & (USD/unit) Table 45. Global Recombinant Human Coagulation Factor IX Price by Type (2027-2032) & (USD/unit) Table 46. Global Recombinant Human Coagulation Factor IX Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Recombinant Human Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Recombinant Human Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application (2021-2026) Table 50. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application (2027-2032) Table 51. Global Recombinant Human Coagulation Factor IX Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Recombinant Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 53. Global Recombinant Human Coagulation Factor IX Sales by Application (2027-2032) & (k units) Table 54. Global Recombinant Human Coagulation Factor IX Sales Market Share by Application (2021-2026) Table 55. Global Recombinant Human Coagulation Factor IX Sales Market Share by Application (2027-2032) Table 56. Global Recombinant Human Coagulation Factor IX Price by Application (2021-2026) & (USD/unit) Table 57. Global Recombinant Human Coagulation Factor IX Price by Application (2027-2032) & (USD/unit) Table 58. Bio-Techne Company Information Table 59. Bio-Techne Business Overview Table 60. Bio-Techne Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Bio-Techne Recombinant Human Coagulation Factor IX Product Portfolio Table 62. Bio-Techne Recent Development Table 63. Cayman Company Information Table 64. Cayman Business Overview Table 65. Cayman Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Cayman Recombinant Human Coagulation Factor IX Product Portfolio Table 67. Cayman Recent Development Table 68. Cusabio Company Information Table 69. Cusabio Business Overview Table 70. Cusabio Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Cusabio Recombinant Human Coagulation Factor IX Product Portfolio Table 72. Cusabio Recent Development Table 73. Grifols Company Information Table 74. Grifols Business Overview Table 75. Grifols Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Grifols Recombinant Human Coagulation Factor IX Product Portfolio Table 77. Grifols Recent Development Table 78. IDELVION Company Information Table 79. IDELVION Business Overview Table 80. IDELVION Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. IDELVION Recombinant Human Coagulation Factor IX Product Portfolio Table 82. IDELVION Recent Development Table 83. NovoPro Bioscience Company Information Table 84. NovoPro Bioscience Business Overview Table 85. NovoPro Bioscience Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. NovoPro Bioscience Recombinant Human Coagulation Factor IX Product Portfolio Table 87. NovoPro Bioscience Recent Development Table 88. Octapharma Company Information Table 89. Octapharma Business Overview Table 90. Octapharma Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Octapharma Recombinant Human Coagulation Factor IX Product Portfolio Table 92. Octapharma Recent Development Table 93. Sino Biological Company Information Table 94. Sino Biological Business Overview Table 95. Sino Biological Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Sino Biological Recombinant Human Coagulation Factor IX Product Portfolio Table 97. Sino Biological Recent Development Table 98. Baxter Company Information Table 99. Baxter Business Overview Table 100. Baxter Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Baxter Recombinant Human Coagulation Factor IX Product Portfolio Table 102. Baxter Recent Development Table 103. Biogen Company Information Table 104. Biogen Business Overview Table 105. Biogen Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Biogen Recombinant Human Coagulation Factor IX Product Portfolio Table 107. Biogen Recent Development Table 108. Diagbio Company Information Table 109. Diagbio Business Overview Table 110. Diagbio Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Diagbio Recombinant Human Coagulation Factor IX Product Portfolio Table 112. Diagbio Recent Development Table 113. Hualan Bio Company Information Table 114. Hualan Bio Business Overview Table 115. Hualan Bio Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Hualan Bio Recombinant Human Coagulation Factor IX Product Portfolio Table 117. Hualan Bio Recent Development Table 118. Sanofi Company Information Table 119. Sanofi Business Overview Table 120. Sanofi Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Sanofi Recombinant Human Coagulation Factor IX Product Portfolio Table 122. Sanofi Recent Development Table 123. ChinaBiologic Company Information Table 124. ChinaBiologic Business Overview Table 125. ChinaBiologic Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. ChinaBiologic Recombinant Human Coagulation Factor IX Product Portfolio Table 127. ChinaBiologic Recent Development Table 128. Shuyang Company Information Table 129. Shuyang Business Overview Table 130. Shuyang Recombinant Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Shuyang Recombinant Human Coagulation Factor IX Product Portfolio Table 132. Shuyang Recent Development Table 133. North America Recombinant Human Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Recombinant Human Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Recombinant Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 136. North America Recombinant Human Coagulation Factor IX Sales by Type (2027-2032) & (k units) Table 137. North America Recombinant Human Coagulation Factor IX Sales Price by Type (2021-2026) & (USD/unit) Table 138. North America Recombinant Human Coagulation Factor IX Sales Price by Type (2027-2032) & (USD/unit) Table 139. North America Recombinant Human Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Recombinant Human Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Recombinant Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 142. North America Recombinant Human Coagulation Factor IX Sales by Application (2027-2032) & (k units) Table 143. North America Recombinant Human Coagulation Factor IX Sales Price by Application (2021-2026) & (USD/unit) Table 144. North America Recombinant Human Coagulation Factor IX Sales Price by Application (2027-2032) & (USD/unit) Table 145. North America Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. North America Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. North America Recombinant Human Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 149. North America Recombinant Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 150. North America Recombinant Human Coagulation Factor IX Sales by Country (2027-2032) & (k units) Table 151. North America Recombinant Human Coagulation Factor IX Sales Price by Country (2021-2026) & (USD/unit) Table 152. North America Recombinant Human Coagulation Factor IX Sales Price by Country (2027-2032) & (USD/unit) Table 153. United States Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 154. Canada Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 155. Mexico Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 156. Europe Recombinant Human Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 157. Europe Recombinant Human Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 158. Europe Recombinant Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 159. Europe Recombinant Human Coagulation Factor IX Sales by Type (2027-2032) & (k units) Table 160. Europe Recombinant Human Coagulation Factor IX Sales Price by Type (2021-2026) & (USD/unit) Table 161. Europe Recombinant Human Coagulation Factor IX Sales Price by Type (2027-2032) & (USD/unit) Table 162. Europe Recombinant Human Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 163. Europe Recombinant Human Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 164. Europe Recombinant Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 165. Europe Recombinant Human Coagulation Factor IX Sales by Application (2027-2032) & (k units) Table 166. Europe Recombinant Human Coagulation Factor IX Sales Price by Application (2021-2026) & (USD/unit) Table 167. Europe Recombinant Human Coagulation Factor IX Sales Price by Application (2027-2032) & (USD/unit) Table 168. Europe Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Europe Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Europe Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Europe Recombinant Human Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 172. Europe Recombinant Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 173. Europe Recombinant Human Coagulation Factor IX Sales by Country (2027-2032) & (k units) Table 174. Europe Recombinant Human Coagulation Factor IX Sales Price by Country (2021-2026) & (USD/unit) Table 175. Europe Recombinant Human Coagulation Factor IX Sales Price by Country (2027-2032) & (USD/unit) Table 176. Germany Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 177. France Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 178. U.K. Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 179. Italy Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 180. Russia Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 181. Spain Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 182. Netherlands Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 183. Switzerland Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 184. Sweden Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 185. Poland Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 186. China Recombinant Human Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 187. China Recombinant Human Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 188. China Recombinant Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 189. China Recombinant Human Coagulation Factor IX Sales by Type (2027-2032) & (k units) Table 190. China Recombinant Human Coagulation Factor IX Sales Price by Type (2021-2026) & (USD/unit) Table 191. China Recombinant Human Coagulation Factor IX Sales Price by Type (2027-2032) & (USD/unit) Table 192. China Recombinant Human Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 193. China Recombinant Human Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 194. China Recombinant Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 195. China Recombinant Human Coagulation Factor IX Sales by Application (2027-2032) & (k units) Table 196. China Recombinant Human Coagulation Factor IX Sales Price by Application (2021-2026) & (USD/unit) Table 197. China Recombinant Human Coagulation Factor IX Sales Price by Application (2027-2032) & (USD/unit) Table 198. Asia Recombinant Human Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 199. Asia Recombinant Human Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 200. Asia Recombinant Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 201. Asia Recombinant Human Coagulation Factor IX Sales by Type (2027-2032) & (k units) Table 202. Asia Recombinant Human Coagulation Factor IX Sales Price by Type (2021-2026) & (USD/unit) Table 203. Asia Recombinant Human Coagulation Factor IX Sales Price by Type (2027-2032) & (USD/unit) Table 204. Asia Recombinant Human Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 205. Asia Recombinant Human Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 206. Asia Recombinant Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 207. Asia Recombinant Human Coagulation Factor IX Sales by Application (2027-2032) & (k units) Table 208. Asia Recombinant Human Coagulation Factor IX Sales Price by Application (2021-2026) & (USD/unit) Table 209. Asia Recombinant Human Coagulation Factor IX Sales Price by Application (2027-2032) & (USD/unit) Table 210. Asia Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. Asia Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. Asia Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. Asia Recombinant Human Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 214. Asia Recombinant Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 215. Asia Recombinant Human Coagulation Factor IX Sales by Country (2027-2032) & (k units) Table 216. Asia Recombinant Human Coagulation Factor IX Sales Price by Country (2021-2026) & (USD/unit) Table 217. Asia Recombinant Human Coagulation Factor IX Sales Price by Country (2027-2032) & (USD/unit) Table 218. Japan Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 219. South Korea Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 220. India Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 221. Australia Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 222. Taiwan Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 223. Southeast Asia Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 224. SAMEA Recombinant Human Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 225. SAMEA Recombinant Human Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 226. SAMEA Recombinant Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 227. SAMEA Recombinant Human Coagulation Factor IX Sales by Type (2027-2032) & (k units) Table 228. SAMEA Recombinant Human Coagulation Factor IX Sales Price by Type (2021-2026) & (USD/unit) Table 229. SAMEA Recombinant Human Coagulation Factor IX Sales Price by Type (2027-2032) & (USD/unit) Table 230. SAMEA Recombinant Human Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 231. SAMEA Recombinant Human Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 232. SAMEA Recombinant Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 233. SAMEA Recombinant Human Coagulation Factor IX Sales by Application (2027-2032) & (k units) Table 234. SAMEA Recombinant Human Coagulation Factor IX Sales Price by Application (2021-2026) & (USD/unit) Table 235. SAMEA Recombinant Human Coagulation Factor IX Sales Price by Application (2027-2032) & (USD/unit) Table 236. SAMEA Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. SAMEA Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 238. SAMEA Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 239. SAMEA Recombinant Human Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 240. SAMEA Recombinant Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 241. SAMEA Recombinant Human Coagulation Factor IX Sales by Country (2027-2032) & (k units) Table 242. SAMEA Recombinant Human Coagulation Factor IX Sales Price by Country (2021-2026) & (USD/unit) Table 243. SAMEA Recombinant Human Coagulation Factor IX Sales Price by Country (2027-2032) & (USD/unit) Table 244. Brazil Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 245. Argentina Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 246. Chile Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 247. Colombia Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 248. Peru Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 249. Saudi Arabia Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 250. Israel Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 251. UAE Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 252. Turkey Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 253. Iran Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 254. Egypt Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 255. Key Raw Materials Table 256. Raw Materials Key Suppliers Table 257. Recombinant Human Coagulation Factor IX Distributors List Table 258. Recombinant Human Coagulation Factor IX Customers List Table 259. Research Programs/Design for This Report Table 260. Authors List of This Report Table 261. Secondary Sources Table 262. Primary Sources List of Figures Figure 1. Recombinant Human Coagulation Factor IX Image Figure 2. Global Recombinant Human Coagulation Factor IX Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Coagulation Factor IX Market Size Share 2021 VS 2025 VS 2032 Figure 4. 500 IU/Bottle Image Figure 5. 250 IU/Bottle Image Figure 6. 2000 IU/Bottle Image Figure 7. 1000 IU/Bottle Image Figure 8. Global Recombinant Human Coagulation Factor IX Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Recombinant Human Coagulation Factor IX Market Size Share 2021 VS 2025 VS 2032 Figure 10. Adult Patients Image Figure 11. Child Patients Image Figure 12. Global Recombinant Human Coagulation Factor IX Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Human Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 14. Global Recombinant Human Coagulation Factor IX Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Region (2021-2032) Figure 17. Global Recombinant Human Coagulation Factor IX Sales (2021-2032) & (k units) Figure 18. Global Recombinant Human Coagulation Factor IX Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Recombinant Human Coagulation Factor IX Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Recombinant Human Coagulation Factor IX Sales YoY (2021-2032) & (k units) Figure 21. Europe Recombinant Human Coagulation Factor IX Sales YoY (2021-2032) & (k units) Figure 22. China Recombinant Human Coagulation Factor IX Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Recombinant Human Coagulation Factor IX Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Recombinant Human Coagulation Factor IX Sales YoY (2021-2032) & (k units) Figure 25. Global Recombinant Human Coagulation Factor IX Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Recombinant Human Coagulation Factor IX Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Recombinant Human Coagulation Factor IX Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Type (2021-2032) Figure 31. Global Recombinant Human Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Recombinant Human Coagulation Factor IX Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Recombinant Human Coagulation Factor IX Sales Market Share by Type (2021-2032) Figure 34. Global Recombinant Human Coagulation Factor IX Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application (2021-2032) Figure 37. Global Recombinant Human Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Recombinant Human Coagulation Factor IX Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Recombinant Human Coagulation Factor IX Sales Market Share by Application (2021-2032) Figure 40. North America Recombinant Human Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 41. North America Recombinant Human Coagulation Factor IX Sales Share by Type (2021-2032) Figure 42. North America Recombinant Human Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 43. North America Recombinant Human Coagulation Factor IX Sales Share by Application (2021-2032) Figure 44. North America Recombinant Human Coagulation Factor IX Revenue Share by Country (2021-2032) Figure 45. North America Recombinant Human Coagulation Factor IX Sales Share by Country (2021-2032) Figure 46. Europe Recombinant Human Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 47. Europe Recombinant Human Coagulation Factor IX Sales Share by Type (2021-2032) Figure 48. Europe Recombinant Human Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 49. Europe Recombinant Human Coagulation Factor IX Sales Share by Application (2021-2032) Figure 50. Europe Recombinant Human Coagulation Factor IX Revenue Share by Country (2021-2032) Figure 51. Europe Recombinant Human Coagulation Factor IX Sales Share by Country (2021-2032) Figure 52. China Recombinant Human Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 53. China Recombinant Human Coagulation Factor IX Sales Share by Type (2021-2032) Figure 54. China Recombinant Human Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 55. China Recombinant Human Coagulation Factor IX Sales Share by Application (2021-2032) Figure 56. Asia Recombinant Human Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 57. Asia Recombinant Human Coagulation Factor IX Sales Share by Type (2021-2032) Figure 58. Asia Recombinant Human Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 59. Asia Recombinant Human Coagulation Factor IX Sales Share by Application (2021-2032) Figure 60. Asia Recombinant Human Coagulation Factor IX Revenue Share by Country (2021-2032) Figure 61. Asia Recombinant Human Coagulation Factor IX Sales Share by Country (2021-2032) Figure 62. SAMEA Recombinant Human Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 63. SAMEA Recombinant Human Coagulation Factor IX Sales Share by Type (2021-2032) Figure 64. SAMEA Recombinant Human Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 65. SAMEA Recombinant Human Coagulation Factor IX Sales Share by Application (2021-2032) Figure 66. SAMEA Recombinant Human Coagulation Factor IX Revenue Share by Country (2021-2032) Figure 67. SAMEA Recombinant Human Coagulation Factor IX Sales Share by Country (2021-2032) Figure 68. Recombinant Human Coagulation Factor IX Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Recombinant Human Coagulation Factor IX Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 500 IU/Bottle
  • 250 IU/Bottle
  • 2000 IU/Bottle
  • 1000 IU/Bottle
Applications
  • Adult Patients
  • Child Patients
Companies covered
  • Bio-Techne
  • Cayman
  • Cusabio
  • Grifols
  • IDELVION
  • NovoPro Bioscience
  • Octapharma
  • Sino Biological
  • Baxter
  • Biogen
  • Diagbio
  • Hualan Bio
  • Sanofi
  • ChinaBiologic
  • Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Human Coagulation Factor IX Market by Type
  3. 1.2.1 Global Recombinant Human Coagulation Factor IX Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 500 IU/Bottle
  5. 1.2.3 250 IU/Bottle
  6. 1.2.4 2000 IU/Bottle
  7. 1.2.5 1000 IU/Bottle
  8. 1.3 Recombinant Human Coagulation Factor IX Market by Application
  9. 1.3.1 Global Recombinant Human Coagulation Factor IX Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Adult Patients
  11. 1.3.3 Child Patients
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Recombinant Human Coagulation Factor IX Market Dynamics
  1. 2.1 Recombinant Human Coagulation Factor IX Industry Trends
  2. 2.2 Recombinant Human Coagulation Factor IX Industry Drivers
  3. 2.3 Recombinant Human Coagulation Factor IX Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Coagulation Factor IX Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant Human Coagulation Factor IX Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant Human Coagulation Factor IX Revenue by Region
  3. 3.2.1 Global Recombinant Human Coagulation Factor IX Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Human Coagulation Factor IX Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant Human Coagulation Factor IX Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant Human Coagulation Factor IX Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant Human Coagulation Factor IX Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant Human Coagulation Factor IX Sales by Region
  9. 3.4.1 Global Recombinant Human Coagulation Factor IX Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant Human Coagulation Factor IX Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant Human Coagulation Factor IX Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant Human Coagulation Factor IX Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant Human Coagulation Factor IX Revenue by Manufacturers
  2. 4.1.1 Global Recombinant Human Coagulation Factor IX Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant Human Coagulation Factor IX Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant Human Coagulation Factor IX Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Human Coagulation Factor IX Sales by Manufacturers
  6. 4.2.1 Global Recombinant Human Coagulation Factor IX Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant Human Coagulation Factor IX Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant Human Coagulation Factor IX Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant Human Coagulation Factor IX Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant Human Coagulation Factor IX Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant Human Coagulation Factor IX Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant Human Coagulation Factor IX Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant Human Coagulation Factor IX Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant Human Coagulation Factor IX Market CR5 and HHI
  16. 4.8.2 2025 Recombinant Human Coagulation Factor IX Tier 1, Tier 2, and Tier 3
5 Recombinant Human Coagulation Factor IX Market by Type
  1. 5.1 Global Recombinant Human Coagulation Factor IX Revenue by Type
  2. 5.1.1 Global Recombinant Human Coagulation Factor IX Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant Human Coagulation Factor IX Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant Human Coagulation Factor IX Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant Human Coagulation Factor IX Sales by Type
  6. 5.2.1 Global Recombinant Human Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human Coagulation Factor IX Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Recombinant Human Coagulation Factor IX Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant Human Coagulation Factor IX Price by Type
6 Recombinant Human Coagulation Factor IX Market by Application
  1. 6.1 Global Recombinant Human Coagulation Factor IX Revenue by Application
  2. 6.1.1 Global Recombinant Human Coagulation Factor IX Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant Human Coagulation Factor IX Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant Human Coagulation Factor IX Sales by Application
  6. 6.2.1 Global Recombinant Human Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant Human Coagulation Factor IX Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Recombinant Human Coagulation Factor IX Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant Human Coagulation Factor IX Price by Application
7 Company Profiles
  1. 7.1 Bio-Techne
  2. 7.1.1 Bio-Techne Company Information
  3. 7.1.2 Bio-Techne Business Overview
  4. 7.1.3 Bio-Techne Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bio-Techne Recombinant Human Coagulation Factor IX Product Portfolio
  6. 7.1.5 Bio-Techne Recent Developments
  7. 7.2 Cayman
  8. 7.2.1 Cayman Company Information
  9. 7.2.2 Cayman Business Overview
  10. 7.2.3 Cayman Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cayman Recombinant Human Coagulation Factor IX Product Portfolio
  12. 7.2.5 Cayman Recent Developments
  13. 7.3 Cusabio
  14. 7.3.1 Cusabio Company Information
  15. 7.3.2 Cusabio Business Overview
  16. 7.3.3 Cusabio Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cusabio Recombinant Human Coagulation Factor IX Product Portfolio
  18. 7.3.5 Cusabio Recent Developments
  19. 7.4 Grifols
  20. 7.4.1 Grifols Company Information
  21. 7.4.2 Grifols Business Overview
  22. 7.4.3 Grifols Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Grifols Recombinant Human Coagulation Factor IX Product Portfolio
  24. 7.4.5 Grifols Recent Developments
  25. 7.5 IDELVION
  26. 7.5.1 IDELVION Company Information
  27. 7.5.2 IDELVION Business Overview
  28. 7.5.3 IDELVION Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 IDELVION Recombinant Human Coagulation Factor IX Product Portfolio
  30. 7.5.5 IDELVION Recent Developments
  31. 7.6 NovoPro Bioscience
  32. 7.6.1 NovoPro Bioscience Company Information
  33. 7.6.2 NovoPro Bioscience Business Overview
  34. 7.6.3 NovoPro Bioscience Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 NovoPro Bioscience Recombinant Human Coagulation Factor IX Product Portfolio
  36. 7.6.5 NovoPro Bioscience Recent Developments
  37. 7.7 Octapharma
  38. 7.7.1 Octapharma Company Information
  39. 7.7.2 Octapharma Business Overview
  40. 7.7.3 Octapharma Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Octapharma Recombinant Human Coagulation Factor IX Product Portfolio
  42. 7.7.5 Octapharma Recent Developments
  43. 7.8 Sino Biological
  44. 7.8.1 Sino Biological Company Information
  45. 7.8.2 Sino Biological Business Overview
  46. 7.8.3 Sino Biological Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sino Biological Recombinant Human Coagulation Factor IX Product Portfolio
  48. 7.8.5 Sino Biological Recent Developments
  49. 7.9 Baxter
  50. 7.9.1 Baxter Company Information
  51. 7.9.2 Baxter Business Overview
  52. 7.9.3 Baxter Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Baxter Recombinant Human Coagulation Factor IX Product Portfolio
  54. 7.9.5 Baxter Recent Developments
  55. 7.10 Biogen
  56. 7.10.1 Biogen Company Information
  57. 7.10.2 Biogen Business Overview
  58. 7.10.3 Biogen Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Biogen Recombinant Human Coagulation Factor IX Product Portfolio
  60. 7.10.5 Biogen Recent Developments
  61. 7.11 Diagbio
  62. 7.11.1 Diagbio Company Information
  63. 7.11.2 Diagbio Business Overview
  64. 7.11.3 Diagbio Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Diagbio Recombinant Human Coagulation Factor IX Product Portfolio
  66. 7.11.5 Diagbio Recent Developments
  67. 7.12 Hualan Bio
  68. 7.12.1 Hualan Bio Company Information
  69. 7.12.2 Hualan Bio Business Overview
  70. 7.12.3 Hualan Bio Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hualan Bio Recombinant Human Coagulation Factor IX Product Portfolio
  72. 7.12.5 Hualan Bio Recent Developments
  73. 7.13 Sanofi
  74. 7.13.1 Sanofi Company Information
  75. 7.13.2 Sanofi Business Overview
  76. 7.13.3 Sanofi Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Sanofi Recombinant Human Coagulation Factor IX Product Portfolio
  78. 7.13.5 Sanofi Recent Developments
  79. 7.14 ChinaBiologic
  80. 7.14.1 ChinaBiologic Company Information
  81. 7.14.2 ChinaBiologic Business Overview
  82. 7.14.3 ChinaBiologic Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 ChinaBiologic Recombinant Human Coagulation Factor IX Product Portfolio
  84. 7.14.5 ChinaBiologic Recent Developments
  85. 7.15 Shuyang
  86. 7.15.1 Shuyang Company Information
  87. 7.15.2 Shuyang Business Overview
  88. 7.15.3 Shuyang Recombinant Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Shuyang Recombinant Human Coagulation Factor IX Product Portfolio
  90. 7.15.5 Shuyang Recent Developments
8 North America
  1. 8.1 North America Recombinant Human Coagulation Factor IX Market Size by Type
  2. 8.1.1 North America Recombinant Human Coagulation Factor IX Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant Human Coagulation Factor IX Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant Human Coagulation Factor IX Price by Type (2021-2032)
  5. 8.2 North America Recombinant Human Coagulation Factor IX Market Size by Application
  6. 8.2.1 North America Recombinant Human Coagulation Factor IX Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant Human Coagulation Factor IX Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant Human Coagulation Factor IX Price by Application (2021-2032)
  9. 8.3 North America Recombinant Human Coagulation Factor IX Market Size by Country
  10. 8.3.1 North America Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant Human Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant Human Coagulation Factor IX Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Human Coagulation Factor IX Market Size by Type
  2. 9.1.1 Europe Recombinant Human Coagulation Factor IX Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant Human Coagulation Factor IX Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant Human Coagulation Factor IX Price by Type (2021-2032)
  5. 9.2 Europe Recombinant Human Coagulation Factor IX Market Size by Application
  6. 9.2.1 Europe Recombinant Human Coagulation Factor IX Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant Human Coagulation Factor IX Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant Human Coagulation Factor IX Price by Application (2021-2032)
  9. 9.3 Europe Recombinant Human Coagulation Factor IX Market Size by Country
  10. 9.3.1 Europe Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant Human Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant Human Coagulation Factor IX Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Recombinant Human Coagulation Factor IX Market Size by Type
  2. 10.1.1 China Recombinant Human Coagulation Factor IX Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant Human Coagulation Factor IX Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant Human Coagulation Factor IX Price by Type (2021-2032)
  5. 10.2 China Recombinant Human Coagulation Factor IX Market Size by Application
  6. 10.2.1 China Recombinant Human Coagulation Factor IX Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant Human Coagulation Factor IX Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant Human Coagulation Factor IX Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Human Coagulation Factor IX Market Size by Type
  2. 11.1.1 Asia Recombinant Human Coagulation Factor IX Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant Human Coagulation Factor IX Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant Human Coagulation Factor IX Price by Type (2021-2032)
  5. 11.2 Asia Recombinant Human Coagulation Factor IX Market Size by Application
  6. 11.2.1 Asia Recombinant Human Coagulation Factor IX Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant Human Coagulation Factor IX Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant Human Coagulation Factor IX Price by Application (2021-2032)
  9. 11.3 Asia Recombinant Human Coagulation Factor IX Market Size by Country
  10. 11.3.1 Asia Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant Human Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant Human Coagulation Factor IX Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Human Coagulation Factor IX Market Size by Type
  2. 12.1.1 SAMEA Recombinant Human Coagulation Factor IX Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant Human Coagulation Factor IX Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant Human Coagulation Factor IX Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant Human Coagulation Factor IX Market Size by Application
  6. 12.2.1 SAMEA Recombinant Human Coagulation Factor IX Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant Human Coagulation Factor IX Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant Human Coagulation Factor IX Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant Human Coagulation Factor IX Market Size by Country
  10. 12.3.1 SAMEA Recombinant Human Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant Human Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant Human Coagulation Factor IX Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant Human Coagulation Factor IX Value Chain Analysis
  2. 13.1.1 Recombinant Human Coagulation Factor IX Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant Human Coagulation Factor IX Production Mode & Process
  6. 13.2 Recombinant Human Coagulation Factor IX Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant Human Coagulation Factor IX Distributors
  9. 13.2.3 Recombinant Human Coagulation Factor IX Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst